Cite
HARVARD Citation
Hosaka, S. et al. (2020). Patient Transfer to Receive Proton Beam Therapy During Intensive Multimodal Therapy is Safe and Feasible for Patients With Newly Diagnosed High-risk Neuroblastoma. Journal of pediatric hematology/oncology. 42 (1), p. . [Online].